Krka, d. d. (LJSE:KRKG)

Market Cap	5.69B
Revenue (ttm)	1.95B
Net Income (ttm)	410.29M
Shares Out	30.58M
EPS (ttm)	13.35
PE Ratio	13.93
Forward PE	15.45
Dividend	8.25 (4.48%)
Ex-Dividend Date	Jul 22, 2025

Volume	13,954
Average Volume	5,305
Open	184.50
Previous Close	184.00
Day's Range	184.00 - 186.00
52-Week Range	127.50 - 187.50
Beta	0.44
RSI	69.82
Earnings Date	May 15, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.